gleevec

美 　英

• 網(wǎng)絡(luò)格列衛(wèi)；甲磺酸伊馬替尼；格列維克

例句

When they tried Gleevec, known generically as imatinib, it had little effect on the cells.

當(dāng)他們嘗試著格列衛(wèi)，通常被稱依馬替尼，它很少對(duì)細(xì)胞有作用。

Some patients have suffered relapses due to acquired point mutations in KIT, which prevents Gleevec from binding to the protein.

一些腫瘤復(fù)發(fā)的病人由于KIT發(fā)生了點(diǎn)突變，這阻止了Gleevec結(jié)合蛋白激酶。

More recently Novartis, a Swiss firm, lost a bitter battle in India over patent protection for Gleevec, a profitable cancer drug.

最近在印度，瑞士公司諾華為保護(hù)“格列衛(wèi)”這一種利潤極高的抗癌藥物的專利權(quán)而戰(zhàn)，最終輸得灰頭灰臉。

In 2001 Novartis, a Swiss drugmaker, won approval for Gleevec, which treats chronic myeloid leukaemia by attacking another abnormal protein.

2001年瑞士的“諾華公司”獲得藥物Gleevec的審批，該藥通過攻擊另一種非正常蛋白治療慢性髓樣白血病。

For those who had received standard doses of Gleevec treatment before, adverse reactions of high-dose Gleevec are mild and tolerable.

對(duì)于曾接受常規(guī)劑量格列衛(wèi)治療的患者，大劑量格列衛(wèi)不良反應(yīng)輕微、多可耐受。

The estimated overall survival rate for patients receiving Gleevec was 88% when considering deaths from all causes.

在進(jìn)行死因分析時(shí)，接受伊馬替尼治療的患者的總體生存率為88%。

All patients have not received Gleevec's molecular targeted therapy preoperatively or postoperatively.

所有病例術(shù)前及術(shù)后均未接受格列衛(wèi)及其他分子靶向治療。

Aim To research the relationship between the 3D structures and bio activities of gleevec.

目的研究小分子有機(jī)生物堿類藥物格列維克的三維結(jié)構(gòu)與生理活性之間的關(guān)系。

Resistance to Gleevec has developed in some patients, and research continues on new drugs to overcome that resistance.

一些病人出現(xiàn)了對(duì)格列衛(wèi)的抗藥性，而且現(xiàn)在依然在研制克服這種抗藥性的新藥。

It is extremely unlikely that drugs which target a single gene like Gleevec will be active against a major fraction of solid tumors.

單一的基因靶向藥物如格列衛(wèi)將對(duì)大多數(shù)實(shí)體腫瘤有效是絕對(duì)不可能的。

Last year Gleevec grossed $4. 3 billion.

去年Gleevec總銷量43億美元。

Morphological evaluation of bone marrow during initial stage of Gleevec therapy for treatment of chronic myelogenous leukemia

骨髓形態(tài)學(xué)評(píng)價(jià)在進(jìn)展期慢性髓細(xì)胞白血病格列衛(wèi)治療初期的意義

The fortunate patient taking Gleevec forever constitutes only one of two new kinds of being in the modern cancer world;

終生服用格列衛(wèi)的那些幸運(yùn)的病人只是構(gòu)成了現(xiàn)代癌癥世界中兩種人的一種；

Targeting anticarcinogen Gleevec and monitoring its therapeutic effect on leukemia

靶向抗癌藥格列衛(wèi)與其治療白血病療效監(jiān)測(cè)

New Breakthrough Medication for Treating Cancer: Gleevec

最新突破的治癌藥

Effect of Gleevec on the growth of pancreatic cancer cell line

甲磺酸伊馬替尼對(duì)胰腺癌細(xì)胞體外生長的影響